Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural aloe vera is a biological intervention derived from the *Aloe barbadensis* Miller plant, specifically utilizing the peel and leaf components. In a research context led by the University of Thessaly, it is being investigated as a transdermal treatment for skeletal muscle damage and exercise-induced aseptic inflammation following intense eccentric exercise. The product contains over 200 bioactive nutrients, including polysaccharides (such as acemannan), anthraquinones, and salicylic acid, which collectively exert anti-inflammatory, antioxidative, analgesic, and potentially anabolic effects. It aims to accelerate recovery kinetics by reducing delayed onset muscle soreness (DOMS), lowering plasma creatine kinase levels, and restoring force-generating capacity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on natural aloe vera.